High-Risk Multiple Myeloma: Redefining Risk and Rethinking Therapy
{{output}}
Despite therapeutic progress, there has been little improvement in the outcome of the 15%-25% of newly diagnosed high-risk multiple myeloma (HRMM), which is characterized by early treatment resistance and very poor survival. HRMM is a substantial clinical prob... ...